Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 45

1.

BAFF inhibition: a new class of drugs for the treatment of autoimmunity.

Liu Z, Davidson A.

Exp Cell Res. 2011 May 15;317(9):1270-7. doi: 10.1016/j.yexcr.2011.02.005. Epub 2011 Feb 17. Review.

2.

Targeting BAFF in autoimmunity.

Davidson A.

Curr Opin Immunol. 2010 Dec;22(6):732-9. doi: 10.1016/j.coi.2010.09.010. Epub 2010 Oct 21. Review.

3.

BAFF: a local and systemic target in autoimmune diseases.

Moisini I, Davidson A.

Clin Exp Immunol. 2009 Nov;158(2):155-63. doi: 10.1111/j.1365-2249.2009.04007.x. Epub 2009 Jul 30. Review.

4.

B cell activating factor, its role in autoimmunity, and targeting in autoimmune diseases.

Krivosikova M, Dallos T, Maslinski W, Buc M.

Bratisl Lek Listy. 2009;110(3):137-45. Review.

PMID:
19507632
5.

[BAFF: A regulatory cytokine of B lymphocytes involved in autoimmunity and lymphoid cancer].

Reyes S LI, León B F, Rozas V MF, González J P, Naves P R.

Rev Med Chil. 2006 Sep;134(9):1175-84. Epub 2006 Dec 12. Review. Spanish.

6.

BAFF, APRIL and human B cell disorders.

Tangye SG, Bryant VL, Cuss AK, Good KL.

Semin Immunol. 2006 Oct;18(5):305-17. Epub 2006 Aug 17. Review.

PMID:
16916610
7.

BAFF blockade for systemic lupus erythematosus: will the promise be fulfilled?

Ramanujam M, Davidson A.

Immunol Rev. 2008 Jun;223:156-74. doi: 10.1111/j.1600-065X.2008.00625.x. Review. Erratum in: Immunol Rev. 2008 Aug;224:296.

PMID:
18613835
8.

BAFF-targeting therapy, a promising strategy for treating autoimmune diseases.

Sun J, Lin Z, Feng J, Li Y, Shen B.

Eur J Pharmacol. 2008 Nov 12;597(1-3):1-5. doi: 10.1016/j.ejphar.2008.08.027. Epub 2008 Aug 30. Review.

PMID:
18793632
9.

BAFF and innate immunity: new therapeutic targets for systemic lupus erythematosus.

Vincent FB, Morand EF, Mackay F.

Immunol Cell Biol. 2012 Mar;90(3):293-303. doi: 10.1038/icb.2011.111. Epub 2012 Jan 10. Review.

PMID:
22231653
10.

B cells and the BAFF/APRIL axis: fast-forward on autoimmunity and signaling.

Mackay F, Silveira PA, Brink R.

Curr Opin Immunol. 2007 Jun;19(3):327-36. Epub 2007 Apr 12. Review.

PMID:
17433868
11.

Does the BAFF dysregulation play a major role in the pathogenesis of systemic lupus erythematosus?

Binard A, Le Pottier L, Saraux A, Devauchelle-Pensec V, Pers JO, Youinou P.

J Autoimmun. 2008 Feb-Mar;30(1-2):63-7. Epub 2007 Dec 21. Review.

PMID:
18155417
12.

Regulation of B cell self-tolerance by BAFF.

Brink R.

Semin Immunol. 2006 Oct;18(5):276-83. Epub 2006 Aug 17. Review.

PMID:
16916609
13.

The BAFF/APRIL system: emerging functions beyond B cell biology and autoimmunity.

Vincent FB, Saulep-Easton D, Figgett WA, Fairfax KA, Mackay F.

Cytokine Growth Factor Rev. 2013 Jun;24(3):203-15. doi: 10.1016/j.cytogfr.2013.04.003. Epub 2013 May 15. Review.

PMID:
23684423
14.

Living in context with the survival factor BAFF.

Cancro MP.

Immunity. 2008 Mar;28(3):300-1. doi: 10.1016/j.immuni.2008.02.010. Review.

15.

Anticytokine therapy impacting on B cells in autoimmune diseases.

Daridon C, Burmester GR, Dörner T.

Curr Opin Rheumatol. 2009 May;21(3):205-10. doi: 10.1097/BOR.0b013e32832a0760. Review.

PMID:
19346949
16.

Functional and clinical aspects of the B-cell-activating factor (BAFF): a narrative review.

Lied GA, Berstad A.

Scand J Immunol. 2011 Jan;73(1):1-7. doi: 10.1111/j.1365-3083.2010.02470.x. Review.

17.
18.

BAFF, APRIL and their receptors: structure, function and signaling.

Bossen C, Schneider P.

Semin Immunol. 2006 Oct;18(5):263-75. Epub 2006 Aug 17. Review.

PMID:
16914324
19.

TACI, an enigmatic BAFF/APRIL receptor, with new unappreciated biochemical and biological properties.

Mackay F, Schneider P.

Cytokine Growth Factor Rev. 2008 Jun-Aug;19(3-4):263-76. doi: 10.1016/j.cytogfr.2008.04.006. Epub 2008 Jun 2. Review.

PMID:
18514565
20.

BAFF AND APRIL: a tutorial on B cell survival.

Mackay F, Schneider P, Rennert P, Browning J.

Annu Rev Immunol. 2003;21:231-64. Epub 2001 Dec 19. Review.

PMID:
12427767
Items per page

Supplemental Content

Write to the Help Desk